Direct whole-genome deep-sequencing of human respiratory syncytial virus A and B from Vietnamese children identifies distinct patterns of inter- and intra-host evolution Open Access

Abstract

Human respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infections in children < 2 years of age. Little is known about RSV intra-host genetic diversity over the course of infection or about the immune pressures that drive RSV molecular evolution. We performed whole-genome deep-sequencing on 53 RSV-positive samples (37 RSV subgroup A and 16 RSV subgroup B) collected from the upper airways of hospitalized children in southern Vietnam over two consecutive seasons. RSV A NA1 and RSV B BA9 were the predominant genotypes found in our samples, consistent with other reports on global RSV circulation during the same period. For both RSV A and B, the M gene was the most conserved, confirming its potential as a target for novel therapeutics. The G gene was the most variable and was the only gene under detectable positive selection. Further, positively selected sites in G were found in close proximity to and in some cases overlapped with predicted glycosylation motifs, suggesting that selection on amino acid glycosylation may drive viral genetic diversity. We further identified hotspots and coldspots of intra-host genetic diversity in the RSV genome, some of which may highlight previously unknown regions of functional importance.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000298
2015-12-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/12/3470.html?itemId=/content/journal/jgv/10.1099/jgv.0.000298&mimeType=html&fmt=ahah

References

  1. Alvarez R., Elbashir S., Borland T., Toudjarska I., Hadwiger P., John M., Roehl I., Morskaya S. S., Martinello R., other authors. 2009; RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother 53:3952–3962 [View Article][PubMed]
    [Google Scholar]
  2. Arnott A., Vong S., Mardy S., Chu S., Naughtin M., Sovann L., Buecher C., Beauté J., Rith S., other authors. 2011; A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype. J Clin Microbiol 49:3504–3513 [View Article][PubMed]
    [Google Scholar]
  3. Baek Y. H., Choi E. H., Song M. S., Pascua P. N., Kwon H. I., Park S. J., Lee J. H., Woo S. I., Ahn B. H., other authors. 2012; Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea. Arch Virol 157:1039–1050 [View Article][PubMed]
    [Google Scholar]
  4. Blanc A., Delfraro A., Frabasile J., Arbiza S. 2005; Genotypes of respiratory syncytial virus group B identified in Uruguay. Arch Virol 150:603–609 [View Article][PubMed]
    [Google Scholar]
  5. Botosso V. F., Zanotto P. M., Ueda M., Arruda E., Gilio A. E., Vieira S. E., Stewien K. E., Peret T. C., Jamal L. F., other authors. 2009; Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus. PLoS Pathog 5:e1000254 [View Article][PubMed]
    [Google Scholar]
  6. Cane P. A. 1997; Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus. J Med Virol 51:297–304[PubMed] [CrossRef]
    [Google Scholar]
  7. Cane P. A., Pringle C. R. 1995; Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein. J Virol 69:2918–2925[PubMed]
    [Google Scholar]
  8. Choudhary M. L., Wadhwa B. S., Jadhav S. M., Chadha M. S. 2013; Complete genome sequences of two human respiratory syncytial virus genotype A strains from India, RSV-A/NIV1114046/11 and RSV-A/NIV1114073/11. Genome Announc 1:e00165–e00113 [View Article][PubMed]
    [Google Scholar]
  9. Coates H. V., Alling D. W., Chanock R. M. 1966; An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol 83:299–313[PubMed]
    [Google Scholar]
  10. Collins P. L., Olmsted R. A., Spriggs M. K., Johnson P. R., Buckler-White A. J. 1987; Gene overlap and site-specific attenuation of transcription of the viral polymerase L gene of human respiratory syncytial virus. Proc Natl Acad Sci U S A 84:5134–5138 [View Article][PubMed]
    [Google Scholar]
  11. Collins P. L., Mink M. A., Stec D. S. 1991; Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. Proc Natl Acad Sci U S A 88:9663–9667 [View Article][PubMed]
    [Google Scholar]
  12. Connors M., Crowe J. E. Jr, Firestone C. Y., Murphy B. R., Collins P. L. 1995; A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes. Virology 208:478–484 [View Article][PubMed]
    [Google Scholar]
  13. Crowe J. E. Jr, Firestone C. Y., Whitehead S. S., Collins P. L., Murphy B. R. 1996; Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene. Virus Genes 13:269–273 [View Article][PubMed]
    [Google Scholar]
  14. Cui G., Qian Y., Zhu R., Deng J., Zhao L., Sun Y., Wang F. 2013; Emerging human respiratory syncytial virus genotype ON1 found in infants with pneumonia in Beijing, China. Emerg Microbes Infect 2:e22 [View Article][PubMed]
    [Google Scholar]
  15. Dapat I. C., Shobugawa Y., Sano Y., Saito R., Sasaki A., Suzuki Y., Kumaki A., Zaraket H., Dapat C., other authors. 2010; New genotypes within respiratory syncytial virus group B genotype BA in Niigata, Japan. J Clin Microbiol 48:3423–3427 [View Article][PubMed]
    [Google Scholar]
  16. Do A. H., van Doorn H. R., Nghiem M. N., Bryant J. E., Hoang T. H., Do Q. H., Van T. L., Tran T. T., Wills B., other authors. 2011; Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004-2008. PLoS One 6:e18176 [View Article][PubMed]
    [Google Scholar]
  17. Do L. A., van Doorn H. R., Bryant J. E., Nghiem M. N., Nguyen Van V. C., Vo C. K., Nguyen M. D., Tran T. H., Farrar J., de Jong M. D. 2012; A sensitive real-time PCR for detection and subgrouping of human respiratory syncytial virus. J Virol Methods 179:250–255 [View Article][PubMed]
    [Google Scholar]
  18. Dormitzer P. R., Grandi G., Rappuoli R. 2012; Structural vaccinology starts to deliver. Nat Rev Microbiol 10:807–813 [View Article][PubMed]
    [Google Scholar]
  19. Edgar R. C. 2004; muscle: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792–1797 [View Article][PubMed]
    [Google Scholar]
  20. Empey K. M., Peebles R. S. Jr, Kolls J. K. 2010; Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. Clin Infect Dis 50:1258–1267 [View Article][PubMed]
    [Google Scholar]
  21. Escribano-Romero E., Rawling J., García-Barreno B., Melero J. A. 2004; The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans. J Virol 78:3524–3532 [View Article][PubMed]
    [Google Scholar]
  22. Eshaghi A., Duvvuri V. R., Lai R., Nadarajah J. T., Li A., Patel S. N., Low D. E., Gubbay J. B. 2012; Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication. PLoS One 7:e32807 [View Article][PubMed]
    [Google Scholar]
  23. Fearns R., Collins P. L., Peeples M. E. 2000; Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus. J Virol 74:6006–6014 [View Article][PubMed]
    [Google Scholar]
  24. Firestone C. Y., Whitehead S. S., Collins P. L., Murphy B. R., Crowe J. E. Jr 1996; Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. Virology 225:419–422 [View Article][PubMed]
    [Google Scholar]
  25. García O., Martín M., Dopazo J., Arbiza J., Frabasile S., Russi J., Hortal M., Perez-Breña P., Martínez I., other authors. 1994; Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J Virol 68:5448–5459[PubMed]
    [Google Scholar]
  26. Gaunt E. R., Jansen R. R., Poovorawan Y., Templeton K. E., Toms G. L., Simmonds P. 2011; Molecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus. PLoS One 6:e17427 [View Article][PubMed]
    [Google Scholar]
  27. Ghildyal R., Ho A., Dias M., Soegiyono L., Bardin P. G., Tran K. C., Teng M. N., Jans D. A. 2009; The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism. J Virol 83:5353–5362 [View Article][PubMed]
    [Google Scholar]
  28. Grad Y. H., Newman R., Zody M., Yang X., Murphy R., Qu J., Malboeuf C. M., Levin J. Z., Lipsitch M., DeVincenzo J. 2014; Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure. J Virol 88:7286–7293 [View Article][PubMed]
    [Google Scholar]
  29. Hall T. 1999; BioEdit: a user-friendly biological sequence aligment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98
    [Google Scholar]
  30. Johnson P. R. Jr, Olmsted R. A., Prince G. A., Murphy B. R., Alling D. W., Walsh E. E., Collins P. L. 1987a; Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol 61:3163–3166[PubMed]
    [Google Scholar]
  31. Johnson P. R., Spriggs M. K., Olmsted R. A., Collins P. L. 1987b; The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci U S A 84:5625–5629 [View Article][PubMed]
    [Google Scholar]
  32. Karron R. A., Buonagurio D. A., Georgiu A. F., Whitehead S. S., Adamus J. E., Clements-Mann M. L., Harris D. O., Randolph V. B., Udem S. A., other authors. 1997; Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci U S A 94:13961–13966 [View Article][PubMed]
    [Google Scholar]
  33. Khor C. S., Sam I. C., Hooi P. S., Chan Y. F. 2013; Displacement of predominant respiratory syncytial virus genotypes in Malaysia between 1989 and 2011. Infect Genet Evol 14:357–360 [View Article][PubMed]
    [Google Scholar]
  34. Korber B. 2000; HIV signature and sequence variation analysis. In Computational Analysis of HIV Molecular Sequences pp. 55–72 Edited by Rodrigo A. G., Learn G. H. Dordrecht: Kluwer;
    [Google Scholar]
  35. Krusat T., Streckert H. J. 1997; Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch Virol 142:1247–1254 [View Article][PubMed]
    [Google Scholar]
  36. Krzywinski M., Schein J., Birol I., Connors J., Gascoyne R., Horsman D., Jones S. J., Marra M. A. 2009; Circos: an information aesthetic for comparative genomics. Genome Res 19:1639–45 [CrossRef]
    [Google Scholar]
  37. Kumaria R., Iyer L. R., Hibberd M. L., Simões E. A., Sugrue R. J. 2011; Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected children. Virol J 8:372[PubMed] [CrossRef]
    [Google Scholar]
  38. Kuo L., Grosfeld H., Cristina J., Hill M. G., Collins P. L. 1996; Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus. J Virol 70:6892–6901[PubMed]
    [Google Scholar]
  39. Kuo L., Fearns R., Collins P. L. 1997; Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA. J Virol 71:4944–4953[PubMed]
    [Google Scholar]
  40. Lamb R. A., Collins P. L., Kolakofsky D., Melero J. A., Nagai Y., Oldstone M. B. A., Pringle C. R., Rima B. K. 2005; Paramyxoviridae. In Eighth Report of the International Committee on Taxonomy of Viruses pp. 655–668 Edited by Fauquet C. M., Mayo M. A., Maniloff J., Desselberger U., Ball L. A. London: Elsevier Academic Press;
    [Google Scholar]
  41. Lee W. J., Kim Y. J., Kim D. W., Lee H. S., Lee H. Y., Kim K. 2012; Complete genome sequence of human respiratory syncytial virus genotype A with a 72-nucleotide duplication in the attachment protein G gene. J Virol 86:13810–13811 [View Article][PubMed]
    [Google Scholar]
  42. Li J., Rahmeh A., Morelli M., Whelan S. P. 2008; A conserved motif in region V of the large polymerase proteins of nonsegmented negative-sense RNA viruses that is essential for mRNA capping. J Virol 82:775–784 [View Article][PubMed]
    [Google Scholar]
  43. Llorente M. T., García-Barreno B., Calero M., Camafeita E., López J. A., Longhi S., Ferrón F., Varela P. F., Melero J. A. 2006; Structural analysis of the human respiratory syncytial virus phosphoprotein: characterization of an alpha-helical domain involved in oligomerization. J Gen Virol 87:159–169 [View Article][PubMed]
    [Google Scholar]
  44. Llorente M. T., Taylor I. A., López-Viñas E., Gomez-Puertas P., Calder L. J., García-Barreno B., Melero J. A. 2008; Structural properties of the human respiratory syncytial virus P protein: evidence for an elongated homotetrameric molecule that is the smallest orthologue within the family of paramyxovirus polymerase cofactors. Proteins 72:946–958 [View Article][PubMed]
    [Google Scholar]
  45. Lo M. S., Brazas R. M., Holtzman M. J. 2005; Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79:9315–9319 [View Article][PubMed]
    [Google Scholar]
  46. Martínez I., Dopazo J., Melero J. A. 1997; Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol 78:2419–2429 [View Article][PubMed]
    [Google Scholar]
  47. Martínez I., Valdés O., Delfraro A., Arbiza J., Russi J., Melero J. A. 1999; Evolutionary pattern of the G glycoprotein of human respiratory syncytial viruses from antigenic group B: the use of alternative termination codons and lineage diversification. J Gen Virol 80:125–130 [View Article][PubMed]
    [Google Scholar]
  48. Matheson J. W., Rich F. J., Cohet C., Grimwood K., Huang Q. S., Penny D., Hendy M. D., Kirman J. R. 2006; Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years. J Med Virol 78:1354–1364 [View Article][PubMed]
    [Google Scholar]
  49. McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., other authors. 2010; The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297–1303 [View Article][PubMed]
    [Google Scholar]
  50. Melero J. A., García-Barreno B., Martínez I., Pringle C. R., Cane P. A. 1997; Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol 78:2411–2418 [View Article][PubMed]
    [Google Scholar]
  51. Mink M. A., Stec D. S., Collins P. L. 1991; Nucleotide sequences of the 3′ leader and 5′ trailer regions of human respiratory syncytial virus genomic RNA. Virology 185:615–624 [View Article][PubMed]
    [Google Scholar]
  52. Moudy R. M., Harmon S. B., Sullender W. M., Wertz G. W. 2003; Variations in transcription termination signals of human respiratory syncytial virus clinical isolates affect gene expression. Virology 313:250–260 [View Article][PubMed]
    [Google Scholar]
  53. Nei M., Gojobori T. 1986; Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3:418–426[PubMed]
    [Google Scholar]
  54. Nielsen R., Yang Z. 1998; Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929–936[PubMed]
    [Google Scholar]
  55. Olmsted R. A., Murphy B. R., Lawrence L. A., Elango N., Moss B., Collins P. L. 1989; Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus. J Virol 63:411–420[PubMed]
    [Google Scholar]
  56. Otto T. D., Sanders M., Berriman M., Newbold C. 2010; Iterative Correction of Reference Nucleotides (iCORN) using second generation sequencing technology. Bioinformatics 26:1704–1707 [View Article][PubMed]
    [Google Scholar]
  57. Palomo C., García-Barreno B., Peñas C., Melero J. A. 1991; The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity. J Gen Virol 72:669–675 [View Article][PubMed]
    [Google Scholar]
  58. Palomo C., Cane P. A., Melero J. A. 2000; Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains. J Med Virol 60:468–474[PubMed] [CrossRef]
    [Google Scholar]
  59. Parveen S., Sullender W. M., Fowler K., Lefkowitz E. J., Kapoor S. K., Broor S. 2006; Genetic variability in the G protein gene of group A and B respiratory syncytial viruses from India. J Clin Microbiol 44:3055–3064 [View Article][PubMed]
    [Google Scholar]
  60. Peret T. C., Hall C. B., Schnabel K. C., Golub J. A., Anderson L. J. 1998; Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol 79:2221–2229 [View Article][PubMed]
    [Google Scholar]
  61. Peret T. C., Hall C. B., Hammond G. W., Piedra P. A., Storch G. A., Sullender W. M., Tsou C., Anderson L. J. 2000; Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis 181:1891–1896 [View Article][PubMed]
    [Google Scholar]
  62. Pond S. L., Frost S. D., Muse S. V. 2005; HyPhy: hypothesis testing using phylogenies. Bioinformatics 21:676–679 [View Article][PubMed]
    [Google Scholar]
  63. Posada D., Crandall K. A. 1998; modeltest: testing the model of DNA substitution. Bioinformatics 14:817–818 [View Article][PubMed]
    [Google Scholar]
  64. Power U. F. 2008; Respiratory syncytial virus (RSV) vaccines - two steps back for one leap forward. J Clin Virol 41:38–44 [View Article][PubMed]
    [Google Scholar]
  65. Rebuffo-Scheer C., Bose M., He J., Khaja S., Ulatowski M., Beck E. T., Fan J., Kumar S., Nelson M. I., Henrickson K. J. 2011; Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. PLoS One 6:e25468 [View Article][PubMed]
    [Google Scholar]
  66. Roca A., Loscertales M. P., Quintó L., Pérez-Breña P., Vaz N., Alonso P. L., Saiz J. C. 2001; Genetic variability among group A and B respiratory syncytial viruses in Mozambique: identification of a new cluster of group B isolates. J Gen Virol 82:103–111 [View Article][PubMed]
    [Google Scholar]
  67. Rueda P., Delgado T., Portela A., Melero J. A., García-Barreno B. 1991; Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies. J Virol 65:3374–3378[PubMed]
    [Google Scholar]
  68. Rueda P., Palomo C., García-Barreno B., Melero J. A. 1995; The three C-terminal residues of human respiratory syncytial virus G glycoprotein (Long strain) are essential for integrity of multiple epitopes distinguishable by antiidiotypic antibodies. Viral Immunol 8:37–46 [View Article][PubMed]
    [Google Scholar]
  69. Salter A., Laoi B. N., Crowley B. 2011; Molecular epidemiology of human respiratory syncytial virus subgroups A and B identified in adults with hematological malignancy attending an Irish hospital between 2004 and 2009. J Med Virol 83:337–347 [View Article][PubMed]
    [Google Scholar]
  70. Shobugawa Y., Saito R., Sano Y., Zaraket H., Suzuki Y., Kumaki A., Dapat I., Oguma T., Yamaguchi M., Suzuki H. 2009; Emerging genotypes of human respiratory syncytial virus subgroup A among patients in Japan. J Clin Microbiol 47:2475–2482 [View Article][PubMed]
    [Google Scholar]
  71. Singh V. 2005; The burden of pneumonia in children: an Asian perspective. Paediatr Respir Rev 6:88–93 [View Article][PubMed]
    [Google Scholar]
  72. Spann K. M., Tran K. C., Chi B., Rabin R. L., Collins P. L. 2004; Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78:4363–4369 [View Article][PubMed]
    [Google Scholar]
  73. Stamatakis A. 2006; RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22:2688–2690 [View Article][PubMed]
    [Google Scholar]
  74. Stec D. S., Hill M. G. III, Collins P. L. 1991; Sequence analysis of the polymerase L gene of human respiratory syncytial virus and predicted phylogeny of nonsegmented negative-strand viruses. Virology 183:273–287 [View Article][PubMed]
    [Google Scholar]
  75. Sullender W. M. 2000; Respiratory syncytial virus genetic and antigenic diversity. Clin Microbiol Rev 13:1–15 [View Article][PubMed]
    [Google Scholar]
  76. Swanson K. A., Settembre E. C., Shaw C. A., Dey A. K., Rappuoli R., Mandl C. W., Dormitzer P. R., Carfi A. 2011; Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc Natl Acad Sci U S A 108:9619–9624 [View Article][PubMed]
    [Google Scholar]
  77. Tan L., Lemey P., Houspie L., Viveen M. C., Jansen N. J., van Loon A. M., Wiertz E., van Bleek G. M., Martin D. P., Coenjaerts F. E. 2012; Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiology. PLoS One 7:e51439 [View Article][PubMed]
    [Google Scholar]
  78. Tawar R. G., Duquerroy S., Vonrhein C., Varela P. F., Damier-Piolle L., Castagné N., MacLellan K., Bedouelle H., Bricogne G., other authors. 2009; Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science 326:1279–1283 [View Article][PubMed]
    [Google Scholar]
  79. Tolley K. P., Marriott A. C., Simpson A., Plows D. J., Matthews D. A., Longhurst S. J., Evans J. E., Johnson J. L., Cane P. A., other authors. 1996; Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virus. Vaccine 14:1637–1646 [View Article][PubMed]
    [Google Scholar]
  80. Trento A., Galiano M., Videla C., Carballal G., García-Barreno B., Melero J. A., Palomo C. 2003; Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol 84:3115–3120 [View Article][PubMed]
    [Google Scholar]
  81. Trento A., Casas I., Calderón A., García-García M. L., Calvo C., Perez-Breña P., Melero J. A. 2010; Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene. J Virol 84:7500–7512 [View Article][PubMed]
    [Google Scholar]
  82. Venter M., Madhi S. A., Tiemessen C. T., Schoub B. D. 2001; Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J Gen Virol 82:2117–2124 [View Article][PubMed]
    [Google Scholar]
  83. Vignuzzi M., Stone J. K., Arnold J. J., Cameron C. E., Andino R. 2006; Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344–348 [View Article][PubMed]
    [Google Scholar]
  84. Vignuzzi M., Wendt E., Andino R. 2008; Engineering attenuated virus vaccines by controlling replication fidelity. Nat Med 14:154–161 [View Article][PubMed]
    [Google Scholar]
  85. Weese D., Emde A. K., Rausch T., Döring A., Reinert K. 2009; RazerS - fast read mapping with sensitivity control. Genome Res 19:1646–1654 [View Article][PubMed]
    [Google Scholar]
  86. Whitehead S. S., Juhasz K., Firestone C. Y., Collins P. L., Murphy B. R. 1998; Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees. J Virol 72:4467–4471[PubMed]
    [Google Scholar]
  87. WHO 2006; Collecting, preserving and shipping specimens for the diagnosis of avian influenza A(H5N1) virus infection. WHO/CDS/EPR/ARO/2006.1. http://www.who.int/csr/resources/publications/surveillance/WHO_CDS_EPR_ARO_2006_1/en/
    [Google Scholar]
  88. Wilm A., Aw P. P., Bertrand D., Yeo G. H., Ong S. H., Wong C. H., Khor C. C., Petric R., Hibberd M. L., Nagarajan N. 2012; LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 40:11189–11201 [View Article][PubMed]
    [Google Scholar]
  89. Yang Z., Wong W. S., Nielsen R. 2005; Bayes empirical Bayes inference of amino acid sites under positive selection. Mol Biol Evol 22:1107–1118 [View Article][PubMed]
    [Google Scholar]
  90. Yoshida L. M., Suzuki M., Yamamoto T., Nguyen H. A., Nguyen C. D., Nguyen A. T., Oishi K., Vu T. D., Le T. H., other authors. 2010; Viral pathogens associated with acute respiratory infections in central Vietnamese children. Pediatr Infect Dis J 29:75–77 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000298
Loading
/content/journal/jgv/10.1099/jgv.0.000298
Loading

Data & Media loading...

Most cited Most Cited RSS feed